Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
19/05/2026 17:24
May 19 (Reuters) - Co-Diagnostics Inc CODX.O: CO-DIAGNOSTICS DEVELOPS EBOLA ASSAY STRATEGY FOLLOWING RECENT GLOBAL OUTBREAK ALERT Source text: ID:nPn6JMxpHa Further company coverage: CODX.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing